Private Testosterone Boom Risks Overtreatment and Pushes Monitoring Costs Onto the NHS
Experts warn in The BMJ that the rapid growth of private testosterone prescribing risks overtreatment, unclear diagnostics, and a hidden ...
Tag: off-label prescribing
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era